L22: Hormone Driven Cancers Flashcards
What are the risk factors for breast cancer
Age High fat diet High BMI Shorter duration of breastfeeding Previous breast disease Family history Oestrogen exposure Early menarche Late menopause No children Alcohol smoking Radiation
How can you have exposure to oestrogen
Oral contraceptive pill
Hormonal replacement therapy
What happens to the risk of breast cancer when you stop taking OCPs/HRT
Decreases
What is the treatment for local disease
Lumpectomy
Mastectomy
Adjuvant radiotherapy
Adjuvant systemic therapy
What is the treatment for invasive breast cancer
Wide local excision with lymph nodes
Radiotherapy
Neo adjuvant chemotherapy
Adjuvant systemic therapy
What is the purpose of systemic therapy
Prevent metastasis to other organs
What does the systemic therapy depend on
The nature of cancer:
I.e if hormone dependent or not
If the cancer is oestrogen dependent what therapy can we use
Taxomifen
Aromatase inhibitors
Gonodotrophin releasing hormone analogue
Who is aramotase inhibitors used on
Post menopausal woman
Who is gonodotrophin releasing hormone used on
Pre menopausal woman
If the cancer is not hormone dependent i.e oestrogen dependent what therapy would we use
Chemotherapy
When we take the tumour out via surgery what is done to the lump
Histology
What is luminal a breast cancer
Oestrogen receptor positive
Progesterone positive
HER2 negative
Where is oestrogen receptor present
In the nucleus
What bins to oestrogen receptors
Oestrogen
What is oestrogen receptor in the nucleus stabilised by
HSP90
What happens to oestrogen receptor (ER) when oestrogen binds to it
Dimerises and phosphorylated
What happens to HSP90 protein when oestrogen binds to ER
Loses its effect
When we have dimerised ER what bind to it
Co activator molecules in
What does the co-activator bound form of ER have exposed
Transcriptional actor factor - TAF 1+2
What is the role of TAF 1 & 2
Binds to DNA and causes the transcription of genes of progesterone receptor, IGF, TGF-alpha
What happens to IGF and TGF-alpha that is released
Binds to insulin growth receptors (IGF) and TGF-alpha receptors on the surface of the cell in a autocrine fashion
What type of receptor is TGF-alpha receptor
Tyrosine kinase receptor
When the receptors are activated what pathway becomes activated
MAP pathway
PI-3 kinase pathway
What does the MAP and PI-3 Kinase pathway result in
Proliferation
Cell growth
Name an example of a selective oestrogen receptor modulator (SERM)
Tamoxifen